August 5, 2025International Journal of Biological and Pharmaceutical Sciences Archive

Neoantigen-driven cancer vaccines: Revolutionizing precision oncology through personalized immunotherapy

View Full Paper

Ask AI

Bookmark

Authors

VNVictor Chinedu NzereoguUniversity of Nigeria COChristopher Chukwujindu Opoh TOTobi John Oluwayemi

Discussion

Member takes

Implication

This review demonstrates that neoantigen-driven cancer vaccines improve immune responses in cancers, suggesting advancements in personalized immunotherapy.

Key Points

Neoantigen-driven cancer vaccines utilize tumor-specific mutations to create tailored immune responses.
Clinical applications of these vaccines have shown promising results, particularly in melanoma and pancreatic cancer.
The methodology incorporates next-generation sequencing and bioinformatics to identify effective neoantigens.
Future improvements may focus on AI tools and cost-reduction strategies to enhance vaccine accessibility.

Cite This Study

Nzereogu et al. (2025) studied this question.

synapsesocial.com/papers/689522189f4f1c896c429e19 https://doi.org/10.53771/ijbpsa.2025.10.1.0063

View Full Paper

Ask AI

Bookmark

Implication

This review demonstrates that neoantigen-driven cancer vaccines improve immune responses in cancers, suggesting advancements in personalized immunotherapy.

Neoantigen-driven cancer vaccines: Revolutionizing precision oncology through personalized immunotherapy

Discussion

Member takes

Implication

Key Points

Cite This Study

Neoantigen-driven cancer vaccines: Revolutionizing precision oncology through personalized immunotherapy

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider